Telmisartan 144701-48-4 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-06
Product Details
- Product NameTelmisartan
- CAS No.144701-48-4
- EINECS No.620-494-7
- MFC33H30N4O2
- MW514.62
- Appearancesolidwhite
- density 1.16
- Melting point 261-263°C
- Water Solubility insoluble
- storage temp. 2-8°C
- Boiling point 771.9±70.0 °C(Predicted)
Company Profile Introduction
Glenmark Pharmaceuticals Limited is a research‐led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus in the therapy areas of Respiratory, Dermatology and Oncology. The company has four research and development centres, ten world‐class manufacturing facilities spread across five continents, and operations in over eighty countries.
In its quest to be among the first few Indian pharmaceutical companies to develop an innovative drug for the world, Glenmark is treading two parallel paths. One pursues the discovery of a novel chemical or biological entity. The second that leads towards scaling the value chain by creating specialty products, like RYALTRIS®, that address gaps in treatment.
Glenmark Pharmaceuticals and its fully owned US subsidiary Ichnos Sciences together have formed an alliance ‘Ichnos Glenmark Innovation’ to use different modalities, technologies and combined expertise to treat cancer. It has a robust pipeline of innovative molecules, in various stages of clinical development across oncology and immunology.
Glenmark is driven by a continuous commitment to create ‘A New Way for a New World’. Harnessing the potential of our core strengths of innovation, research, and scientific knowledge, we remain determined to consistently challenge established treatment paradigms. It allows us to identify and deliver promising solutions that make a considerable difference to the lives of patients in diverse geographies.
Supplier other products
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- 144701-48-4 95-99%
- Inquiry
- 2024-09-11
-
VIP1年
- Aptra Synthesis Pvt Ltd
- 144701-48-4 Telmisartan 99%
- Inquiry
- 2024-05-20
-
VIP1年
- GN PAL Speciality Molecules LLP
- 144701-48-4 Telmisartan 98%
- Inquiry
- 2024-05-15
-
VIP1年
- Gangwal Healthcare Pvt Ltd
- Telmisartan Granules 144701-48-4 98%
- Inquiry
- 2024-04-27
-
VIP1年
- Molsyns Research
- Telmisartan Reference Standard 98%
- Inquiry
- 2024-04-01
-
VIP1年
- Sibram Pharmaceutical
- Telmisartan 144701-48-4 99%
- Inquiry
- 2024-03-16
-
VIP1年
- Mylan Laboratories Ltd
- 144701-48-4 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Suvan LifeSciences (formerly Sansh Biotech Pvt Ltd)
- Telmisartan 144701-48-4 98%
- Inquiry
- 2024-02-29
-
VIP1年
- BDR Pharmaceuticals International Pvt Ltd
- Telmisartan 98%
- Inquiry
- 2024-02-24
-
VIP1年
- Globela Industry Pvt Ltd
- 144701-48-4 98%
- Inquiry
- 2024-02-22
- Since:2020-01-01
- Address: "Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (E) Mumbai Maharas